Central adenosine A2A receptors:: an overview

被引:130
作者
Moreau, JL [1 ]
Huber, G [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Preclin CNS Res, Div Pharma, PRPN, CH-4070 Basel, Switzerland
关键词
adenosine; A(2A) receptor; behavioural function; neuropsychiatric disorder;
D O I
10.1016/S0165-0173(99)00059-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent advances in molecular biology, biochemistry, cell biology and behavioral pharmacology together with the development of more selective ligands to the various adenosine receptors have increased our understanding of the functioning of central adenosine A(2A) receptors. The A(2A) receptor is one of four adenosine receptors found in the brain. Its expression is highest in striatum, nucleus accumbens and olfactory tubercles, although it also occurs in neurons and microglia in most other brain regions. The receptor has seven transmembrane domains and couples via Gs to adenyl cyclase stimulation. Antagonistic interactions between A(2A) receptors and dopamine D-2 receptors have been described, as stimulation of the A(2A) receptor leads to a reduction in the affinity of D-2 receptors for D-2 receptor agonists, The A(2A) receptor is thought to play a role in a number of physiological responses and pathological conditions. Indeed, A(2A) receptor antagonists may be useful for the treatment of acute and chronic neurodegenerative disorders such as cerebral ischemia or Parkinson's disease. A(2A) receptor agonists may treat certain types of seizures or sleep disorders. This review discusses the characteristics, distribution, pharmacochemical properties and regulation of central A(2A) receptors, as well as A(2A) receptor-mediated behavioural responses and their potential role in various neuropsychiatric disorders. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:65 / 82
页数:18
相关论文
共 198 条
  • [1] Effects of repeated administration of selective adenosine A(1) and A(2A) receptor agonists on pentylenetetrazole-induced convulsions in the rat
    Adami, M
    Bertorelli, R
    Ferri, N
    Foddi, MC
    Ongini, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) : 383 - 389
  • [2] EFFECTS OF (-)-N6-(R-PHENYLISOPROPYL)-ADENOSINE(PIA) AND CAFFEINE ON NOCICEPTION AND MORPHINE-INDUCED ANALGESIA, TOLERANCE AND DEPENDENCE IN MICE
    AHLIJANIAN, MK
    TAKEMORI, AE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (02) : 171 - 179
  • [3] DESENSITIZATION OF THE STIMULATORY A2-ADENOSINE RECEPTOR ADENYLATE-CYCLASE SYSTEM IN VASCULAR SMOOTH-MUSCLE CELLS FROM RAT AORTA
    ANANDSRIVASTAVA, MB
    CANTIN, M
    BALLAK, M
    PICARD, S
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 62 (02) : 273 - 279
  • [4] BALDO BA, 1996, SOC NEUR ABSTR, V22
  • [5] BALDO BA, 1998, BEHAV PHARMACOL, V9, pS12
  • [6] ANTAGONISTIC EFFECTS OF CAFFEINE AND YOHIMBINE IN ANIMAL TESTS OF ANXIETY
    BALDWIN, HA
    JOHNSTON, AL
    FILE, SE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 159 (02) : 211 - 215
  • [7] ROLE OF ADENOSINE A(2A) RECEPTORS IN THE NUCLEUS-ACCUMBENS
    BARRACO, RA
    MARTENS, KA
    PARIZON, M
    NORMILE, HJ
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (03) : 545 - 553
  • [8] ANTICONVULSANT EFFECTS OF ADENOSINE-ANALOGS ON AMYGDALOID-KINDLED SEIZURES IN RATS
    BARRACO, RA
    SWANSON, TH
    PHILLIS, JW
    BERMAN, RF
    [J]. NEUROSCIENCE LETTERS, 1984, 46 (03) : 317 - 322
  • [9] BARRACO RA, 1995, J NEUROCHEM, V65, P1604
  • [10] Binding of the novel nonxanthine A(2A) adenosine receptor antagonist [H-3]SCH58261 to coronary artery membranes
    Belardinelli, L
    Shryock, JC
    Ruble, J
    Monopoli, A
    Dionisotti, S
    Ongini, E
    Dennis, DM
    Baker, SP
    [J]. CIRCULATION RESEARCH, 1996, 79 (06) : 1153 - 1160